Jing Chen

Jing Chen

Auto-generated profile, based on publicly available information

Jing Chen

Department of Medicine, The University of Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
HFHao Fan
Hao Fan
SXSiyuan Xia
Siyuan Xia
JXJunhong Xiang
Junhong Xiang
YLYuancheng Li
Yuancheng Li
MRMatthew O. Ross
Matthew O. Ross
JCJing Chen
Jing Chen
Diet-derived nutrients are inextricably linked to human physiology by providing energy and biosynthetic building blocks and by functioning as regulatory molecules. However, the mechanisms by which circulating nutrients in the human body influence specific physiological processes remain largely unknown. Here we use a blood nutrient compound library-based screening approach to demonstrate that dietary trans-vaccenic acid (TVA) directly promotes effector CD8+ T cell function and anti-tumour immunity in vivo. TVA is the predominant form of trans-fatty acids enriched in human milk, but the human body cannot produce TVA endogenously1. Circulating TVA in humans is mainly from ruminant-derived foods including beef, lamb and dairy products such as milk and butter2,3, but only around 19% or 12% of dietary TVA is converted to rumenic acid by humans or mice, respectively4,5. Mechanistically, TVA inactivates the cell-surface receptor GPR43, an immunomodulatory G protein-coupled receptor activated by its short-chain fatty acid ligands6–8. TVA thus antagonizes the short-chain fatty acid agonists of GPR43, leading to activation of the cAMP–PKA–CREB axis for enhanced CD8+ T cell function. These findings reveal that diet-derived TVA represents a mechanism for host-extrinsic reprogramming of CD8+ T cells as opposed to the intrahost gut microbiota-derived short-chain fatty acids. TVA thus has translational potential for the treatment of tumours.

20 July 2021 in Molecular Cell
Verified
Journal Article
Closed access
DCDong Chen
Dong Chen
SXSiyuan Xia
Siyuan Xia
RZRukang Zhang
Rukang Zhang
YLYuancheng Li
Yuancheng Li
CFChristopher A. Famulare
Christopher A. Famulare
JCJing Chen
Jing Chen

25 February 2026 in Nature
Verified
Journal Article
Closed access
LYLuojia Yang
Luojia Yang
PRPaul A. Renauer
Paul A. Renauer
KTKaiyuan Tang
Kaiyuan Tang
JSJosh Saskin
Josh Saskin
LZLiqun Zhou
Liqun Zhou
SCSidi Chen
Sidi Chen

12 April 2022 in Molecular Cell
Verified
Journal Article
Closed access
XGXue Gao
Xue Gao
YLYijie Liu
Yijie Liu
YLYuancheng Li
Yuancheng Li
HFHao Fan
Hao Fan
RWRong Wu
Rong Wu
JCJing Chen
Jing Chen

11 December 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YCYan-Hong Cui
Yan-Hong Cui
JWJiangbo Wei
Jiangbo Wei
HFHao Fan
Hao Fan
WLWenlong Li
Wenlong Li
LZLijie Zhao
Lijie Zhao
YHYu-Ying He
Yu-Ying He
Here, we show that vitamin E succinate (VES) acts as a degrader for the m 6 A RNA demethylase fat mass and obesity-associated protein (FTO), thus suppressing tumor growth and resistance to immunotherapy. FTO is ubiquitinated by its E3 ligase DTX2, followed by UFD1 recruitment and subsequent degradation in the proteasome. VES binds to FTO and DTX2, leading to enhanced FTO–DTX2 interaction, FTO ubiquitination, and degradation in FTO-dependent tumor cells. VES suppressed tumor growth and enhanced antitumor immunity and response to immunotherapy in vivo in mouse models. Genetic FTO knockdown or VES treatment increased m 6 A methylation in the LIF (Leukemia Inhibitory Factor) gene and decreased LIF mRNA decay, and thus sensitized melanoma cells to T cell–mediated cytotoxicity. Taken together, our findings reveal the underlying molecular mechanism for FTO protein degradation and identify a dietary degrader for FTO that inhibits tumor growth and overcomes immunotherapy resistance.

30 September 2024 in Current Opinion in Immunology
Verified
Journal Article
Closed access
FZFreya Q Zhang
Freya Q Zhang
JCJing Chen
Jing Chen
HFHao Fan
Hao Fan